Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Provention Bio (PRVB)
NASDAQ:PRVB
Provention Bio (PRVB) Stock Price & Analysis
0 Followers
PRVB Stock Chart & Stats
Day’s Range$24.98 - $25
52-Week Range― - ―
Previous Close$24.23
Volume9.12M
Average Volume (3M)N/A
Market Cap
$2.37B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,967,981
30 Day Avg. Volume2,084,779
Standard Deviation0.41
R-Squared0.11
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)219.86
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$25.00Price Target Upside0.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Provention Bio News
Pre-EarningsProvention Bio (PRVB) Q4 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PRVB FAQ
What was Provention Bio’s price range in the past 12 months?
Currently, no data Available
What is Provention Bio’s market cap?
Currently, no data Available
When is Provention Bio’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Provention Bio’s earnings last quarter?
Currently, no data Available
Is Provention Bio overvalued?
According to Wall Street analysts Provention Bio’s price is currently Undervalued.
Does Provention Bio pay dividends?
Provention Bio does not currently pay dividends.
What is Provention Bio’s EPS estimate?
Provention Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Provention Bio have?
Currently, no data Available
What happened to Provention Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Provention Bio?
Among the largest hedge funds holding Provention Bio’s share is Gotham Asset Management LLC. It holds Provention Bio’s shares valued at 334K.
---
Provention Bio Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
Provention Bio
Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D); PRV-015 for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 for Crohn's disease; PRV-300 for ulcerative colitis; PRV-3279 for the treatment of lupus; and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of T1D onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Lebanon, NJ.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---